001965:SZSEChina Merchants Expressway Network & Technology Holdings Co.,Ltd. Analysis
Data as of 2026-03-07 - not real-time
CN¥9.85
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
China Merchants Expressway Network trades at ¥9.85, comfortably above its 20‑day (¥9.67) and 50‑day (¥9.72) moving averages, indicating short‑term momentum, yet it remains well below the 200‑day average (¥10.73), suggesting longer‑term pressure. Technical indicators are mixed: the MACD histogram is positive and the signal line is bullish, while the RSI sits at a neutral 57. Volume is increasing, supporting the recent price gains. The stock’s PE of 13.3 is dramatically lower than the industry average of 29.4, and the price‑to‑book of 1.10 aligns closely with book value, marking it as undervalued on a fundamentals basis. A dividend yield of 4.23% with a payout ratio of 56% is backed by solid operating cash flow (¥6.64 bn) and free cash flow (¥4.18 bn), indicating sustainable income for shareholders. The company’s beta of 0.06 points to very low market sensitivity, while 30‑day volatility of 18.5% is moderate for the sector. Despite a recent revenue contraction of 1.7%, margins remain healthy (gross 31%, operating 26%, profit 42%) and EPS is projected to rise from 0.74 to 0.88, reflecting modest earnings growth. Debt levels are high (debt‑to‑equity 66), but the balance sheet is cushioned by ample cash (¥10.22 bn). The DCF model suggests a fair value upside of roughly 32%, and analyst consensus targets around ¥13, reinforcing the upside potential. Overall, the combination of strong dividend, low beta, and valuation discount makes the stock attractive, though the bearish long‑term trend and leverage warrant caution.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Price above 20‑day and 50‑day SMAs
- Bullish MACD histogram and increasing volume
- High dividend yield with sustainable payout
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant valuation discount vs industry PE
- Projected EPS growth and strong cash generation
- Analyst target price ~¥13 indicating upside
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Low beta and stable infrastructure demand
- High leverage requiring monitoring
- Sustainable dividend providing steady return
Key Metrics & Analysis
Financial Health
Revenue Growth-1.70%
Profit Margin41.94%
P/E Ratio13.3
ROE6.41%
ROA1.01%
Debt/Equity66.32
P/B Ratio1.1
Op. Cash FlowCN¥6.6B
Free Cash FlowCN¥4.2B
Industry P/E29.4
Technical Analysis
TrendBearish
RSI57.2
SupportCN¥9.38
ResistanceCN¥9.86
MA 20CN¥9.67
MA 50CN¥9.72
MA 200CN¥10.73
MACDBullish
VolumeIncreasing
Fear & Greed Index68.77
Valuation
Fair ValueCN¥1.27
Target PriceCN¥13.05
Upside/Downside32.49%
GradeUndervalued
TypeBlend
Dividend Yield4.23%
Risk Assessment
Beta0.06
Volatility18.53%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.